Financing channel feed – Endpoints News

Financing channel feed

Three biotechs price hefty IPOs just before the weekend, while a fourth and a SPAC seek spots on Wall Street

4 years ago

Kodiak turns down $125M payment from Baker Bros. deal, slashes royalty cap by 55%

4 years ago

After slicing and dicing TCRs for 8 years, Swedish biotech reloads to angle for a spot in crowded cell therapy space

4 years ago

From cellist to synthetic cell-ist: Jeffrey Kim scores $23M to reimagine blood tests, cell therapy

4 years ago

Prepping for yet more pricey rare disease drugs, UK launches £340M 'Innovative Medicines Fund'

4 years ago

Hemab, still playing coy, gets its first major fundraise for hemophilia bispecifics

4 years ago

Building off Pfizer investment, microbiome-focused Vedanta expands new fundraise to launch 2 studies

4 years ago

As healthcare heats up on HKEX, Qiming sets up $500M fund dedicated to public companies

4 years ago

Healthcare venture capital has already blown away 2020 records, but does it have the juice to keep growing?

4 years ago

IsoPlexis aims to steer its 'barcodes' to Nasdaq as Asia-focused SPAC launches merger efforts

4 years ago

The pivot: Turnstone Biologics opens a new chapter with a switch to clinical development and a new venture round to pay for it

4 years ago

On a mission to treat patients not covered by Luxturna, Horama refuels with a Series B expansion and a new name

4 years ago

A Novartis castoff with a troubled past headlines Chinese biotech's Hong Kong IPO quest

4 years ago

Can a next-gen take on a deadly weight loss pill conquer cardiometabolic diseases? A Medicxi-backed startup thinks so

4 years ago

GHO Capital Partners doubles its last raise, closing on a massive $2B-plus to advance European healthcare

4 years ago

The next SPAC is here, coming from a pharma e-commerce CEO, as a Florida biotech prices at the low end

4 years ago

A pair of young biotech execs snag a mega-round for their late-stage ALS drug as the FDA signals a more flexible approach to an OK

4 years ago

On a mission to support 'underserved' European startups, Panakès Partners dips into the biotech sector with its latest fund

4 years ago

Chinese antibody player chases Hong Kong IPO with lead Rituxan challenger ready for late-stage test

4 years ago

Months after Amgen's landmark KRAS approval, Chris Varma bags a crossover round for next-gen candidate

4 years ago

PureTech-backed Gelesis wins biotech's latest SPAC deal, planning to bring weight loss product to up to 150M Americans

4 years ago

IPOs continue to bustle as three more biotechs prepare to make the Nasdaq leap

4 years ago

Tillman Gerngross is betting well over $500M that the pandemic will never really end. Here’s the IPO pitch

4 years ago

Regeneron, already an institution in NY, earns Cuomo's backing for a $1.8B expansion at Tarrytown hive

4 years ago

First page Previous page 69 70 717273 74 75 Next page Last page